These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 8641737)
21. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II. Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065 [TBL] [Abstract][Full Text] [Related]
22. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Lima CV; Paula RD; Resende FL; Khosla MC; Santos RA Hypertension; 1997 Sep; 30(3 Pt 2):542-8. PubMed ID: 9322979 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits. Weinstock M; Gorodetsky E J Cardiovasc Pharmacol; 1995 Mar; 25(3):501-7. PubMed ID: 7769820 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin-(1-7) antagonist, A-779, microinjection into the caudal ventrolateral medulla of renovascular hypertensive rats restores baroreflex bradycardia. Cangussu LM; de Castro UG; do Pilar Machado R; Silva ME; Ferreira PM; dos Santos RA; Campagnole-Santos MJ; Alzamora AC Peptides; 2009 Oct; 30(10):1921-7. PubMed ID: 19577603 [TBL] [Abstract][Full Text] [Related]
26. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat. Junggren IL; Zhao X; Sun X; Hedner T J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734 [TBL] [Abstract][Full Text] [Related]
27. Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus. Yang RH; Jin H; Wyss JM; Oparil S Hypertension; 1992 May; 19(5):475-81. PubMed ID: 1568766 [TBL] [Abstract][Full Text] [Related]
28. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060 [TBL] [Abstract][Full Text] [Related]
29. Brain "ouabain" and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats. Huang BS; Leenen FH Hypertension; 1996 Dec; 28(6):1005-12. PubMed ID: 8952589 [TBL] [Abstract][Full Text] [Related]
30. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences. Bunkenburg B; Schnell C; Baum HP; Cumin F; Wood JM Hypertension; 1991 Sep; 18(3):278-88. PubMed ID: 1889842 [TBL] [Abstract][Full Text] [Related]
31. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats. DePasquale MJ; Fossa AA; Holt WF; Mangiapane ML Hypertension; 1992 Jun; 19(6 Pt 2):668-71. PubMed ID: 1592465 [TBL] [Abstract][Full Text] [Related]
32. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB Hypertension; 1990 May; 15(5):459-68. PubMed ID: 2185150 [TBL] [Abstract][Full Text] [Related]
33. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors. Brännström K; Morsing P; Arendshorst WJ Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts. Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310 [TBL] [Abstract][Full Text] [Related]
36. Improvement in baroreflex function by an oral angiotensin receptor antagonist in rats with myocardial infarction. Nishizawa M; Kumagai H; Ichikawa M; Oshima N; Suzuki H; Saruta T Hypertension; 1997 Jan; 29(1 Pt 2):458-63. PubMed ID: 9039142 [TBL] [Abstract][Full Text] [Related]
37. Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats. Kangussu LM; Guimaraes PS; Nadu AP; Melo MB; Santos RA; Campagnole-Santos MJ Neuropharmacology; 2015 Oct; 97():58-66. PubMed ID: 25983274 [TBL] [Abstract][Full Text] [Related]
38. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats. Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816 [TBL] [Abstract][Full Text] [Related]
39. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II. Gorbea-Oppliger VJ; Fink GD J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Fontes MA; Martins Pinge MC; Naves V; Campagnole-Santos MJ; Lopes OU; Khosla MC; Santos RA Brain Res; 1997 Mar; 750(1-2):305-10. PubMed ID: 9098557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]